No phaseNot yet recruiting

Outpatient Pramlintide Study

An Outpatient Crossover Study to Evaluate Insulin and Pramlintide Versus Insulin Alone Delivery Strategy

Sponsor
Oregon Health and Science University (Academic or other)
Enrollment
26 planned
Conditions
Type 1 Diabetes
Interventions
Single-hormone automated insulin delivery system; Dual-hormone automated insulin and pramlintide delivery system
Ages
adults, older adults
Registry
NCT07914621

Full record on ClinicalTrials.gov

From the registry

The primary purpose of this study is to compare the performance of a dual-hormone automated insulin delivery (AID) system that delivers both insulin and pramlintide with an AID that only delivers insulin. Our hypothesis is that people using the dual-hormone AID will have a significantly increased percent time in range (70-180 mg/dL) compared with when they use a single-hormone insulin-only AID. Both systems are designed to automatically dose meal insulin if the participant forgets to enter their meal insulin at the time of their meals.

Primary outcomes

  • Percent of time with sensed glucose between 70-180 mg/dl during the daytime

History

  1. Primary completion expected

  2. Last registry update

  3. Registered

  4. Started